Better Health,
Brighter Future
Newsroom
Careers
Investors
Patients
HCPs
Worldwide
Who We Are
About Takeda
How can we do more for our patients?
Everything at Takeda starts with this question.
Learn more
Company Information
Company Facts
History
Worldwide Offices
Executive Leadership
Positions
How We Work
Life at Takeda
Design Concept
Where we work
Corporate Philosophy
Our People
Corporate Governance
Risk & Crisis Management
Global Ethics & Compliance
From the CEO
Contact Us
Celebrating the grand opening of Takeda Global Headquarters
LEARN MORE
What We Do
Our Business
Takeda continues its transformation into an agile and innovative global pharmaceutical leader, serving the needs of patients and physicians worldwide.
Learn more
Research & Development
Ecosystem for Health Innovation
Our Pipeline
Takeda Clinical Trial Transparency
Investigator Initiated Sponsored Research
Therapeutic Areas
Our Products
Alliances & Partnerships
Access to Medicines
Suppliers
Sustainable Procurement
Supplier Code of Conduct
Supplier Diversity
Pharmaceutical Supply Chain Initiative
Supplier Qualification & Due Diligence
T-CiRA
We focus on our core therapeutic areas.
LEARN MORE
Our Stories
Our Stories
A selection of stories related to Innovation, Caring and Heritage
Learn more
Innovation
Quality at Takeda
The Key Elements at the Heart of Our Innovation
Caring
Medicine for the World
Safeguarding Plant Diversity
Takeda at TICAD
Going Beyond Medicines
Change the World
Healthcare for All
Shared Knowledge for a Better Life for All
Heritage
Keys to Aging Gracefully
Shared Knowledge for a Better Life for All
LEARN MORE
Corporate Responsibility
Takeda's CSR
Takeda is committed to creating corporate value by developing outstanding pharmaceutical products and conducting corporate citizenship activities.
LEARN MORE
Our CSR Philosophy
Human Rights
Labor
Environment
Anti-Corruption
Activities
Global CSR Program
SDGs
Takeda Initiative
IDEEL Program
HERhealth
Global Relay for Life
Digital Birth Registration
Corporate Citizenship Videos
Sustainable Value Report
Takeda is committed to contributing to the long-term health of people through disease prevention.
LEARN MORE
HOME
Newsroom
News Releases
Share:
Newsroom
News Releases
In the News
Featured Topics
Corporate Materials
Social Media
Message from the CEO
News Releases
Enter
All
Last 12 months
2017
2016
2015
2014
November 2018
November 15, 2018
11/15/2018
Takeda Announces Issuance of Unsecured U.S. Dollar Denominated Senior Notes
November 15, 2018
11/15/2018
Takeda Announces Pricing of its Unsecured Euro Denominated Senior Notes
November 12, 2018
11/12/2018
Takeda Announces Publication of Circular and Notice of Extraordinary General Meeting of Shareholders in relation to the Proposed Acquisition of Shire
November 8, 2018
11/8/2018
Takeda Announces Issuance of Unsecured Euro Denominated Senior Notes
November 7, 2018
11/7/2018
Takeda Announces Launch of Entyvio® (vedolizumab) for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis in Japan
November 1, 2018
11/1/2018
Takeda to Present Data During 60th American Society of Hematology Annual Meeting on Wide Array of Treatment Needs for Blood Cancers
October 2018
October 31, 2018
10/31/2018
Takeda Reports Second Quarter FY2018 Results
October 31, 2018
10/31/2018
Notice of the Revised Forecast of Consolidated Financials for FY2018 (IFRS)
October 26, 2018
10/26/2018
Takeda comments on ongoing Phase 1 review by the European Commission of the proposed acquisition of Shire plc
1
2
3
4
5
TOP
